The Ad5/3-E2F-d24-vIL2 effectively mitigated the immunosuppressive TME in human ovarian cancer by augmenting the cytotoxic activities of NK cells and T lymphocytes.65 The gene discussed is EZR; the disease is ovarian cancer.